Clinical trial · Observational
HPV Infection and Cervical Neoplasm in Women With Inflammatory Bowel Disease: a Cross-sectional Study
NCT03055130CI-TRIAL-00026004unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The associations between female inflammatory bowel disease (IBD) patients and human papilloma virus (HPV) infection and cervical neoplasia (dysplasia or cancer) were unclear. Especially there was no data for Chinese IBD population. So we investigated the incidence and risk factors of HPV infection and cervical neoplasia (dysplasia or cancer) in female IBD patient.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Neoplasm | Cervical Neoplasm | ONTOLOGY_EXACT | 0.98 |
| HPV-Related Cervical Carcinoma | Human Papillomavirus-Related Cervical Carcinoma | ALIAS | 0.90 |
| Inflammatory Bowel Diseases | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Thinprep Cytology Test (TCT) and HPV infection types were tested by gynecologist | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Case group
- description
- Female IBD patients who had sexual life between 21-60 years-old were recruited.
- interventionNames
- Other: Thinprep Cytology Test (TCT) and HPV infection types were tested by gynecologist
- label
- control group
- description
- Female people who perform physical examination in our hospital between 21-60 years-old were recruited as control during the study period.
- interventionNames
- Other: Thinprep Cytology Test (TCT) and HPV infection types were tested by gynecologist
Primary outcomes (2)
- measure
- The different infection rate of HPV between controls and patients by detecting HPV-DNA using reverse dot-blot method.
- timeFrame
- July 2015 to July 2017
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria: 1. between 20-60 years old; 2. Patients diagnosed as IBD according to previously established international criteria Exclusion Criteria: 1\. Patients refuse to participating
References
Publications (0)
Data not yet available
No reference posted for this study.